3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: March 6, 2013
Period of Report: March 4, 2013
Accession Number: 0001437749-13-002419

View Document ↗ View on SEC.gov ↗